CNSC Announces its Decision to Amend Canadian Light Source Incorporated’s Operating Licence
FOR IMMEDIATE RELEASE
July 29, 2011
Following a public hearing held on June 8, 2011, in Ottawa, Ontario, the Canadian Nuclear Safety Commission (CNSC) announced today its decision to amend Canadian Light Source Incorporated (CLSI)’s licence to refer to the updated CLSI Quality Manual and to modify the occupancy and access control to Experimental Area 2 to prepare the area for the installation of a linear accelerator for the production of Molybdenum-99, a medical isotope. The installation is located in Saskatoon, Saskatchewan.
During the one-day hearing, the Commission received and considered CNSC staff recommendations and the submissions from CLSI. There were no interventions from the public.
The Commission is satisfied that the licensee meets the requirements of section 24 of the Nuclear Safety and Control Act.The Commission concludes that CLSI is qualified to perform the activities that will be permitted under the amended licence and that it will make adequate provision for the protection of the environment, the health and safety of persons, and the maintenance of national security and measures required to implement international obligations to which Canada has agreed.
A Record of Proceedings, including Reasons for Decision and transcripts of the hearing are available on the CNSC Web site at www.nuclearsafety.gc.ca, or by contacting the CNSC. The webcast of the hearing is also archived on the same site for a period of 90 days.
The Canadian Nuclear Safety Commission (CNSC) regulates the use of nuclear energy and materials to protect the health, safety and security of Canadians and the environment; and to respect Canada's international commitments on the peaceful use of nuclear energy.
Aurèle Gervais Media and Community Relations Canadian Nuclear Safety Commission 613-996-6860